Ignite Creation Date:
2024-05-05 @ 4:41 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00293488
Status:
COMPLETED
Last Update Posted:
2016-06-23
First Post:
2006-02-16
Brief Title:
SL-11047 in Treating Patients With Relapsed or Refractory Lymphoma
Sponsor:
Progen Pharmaceuticals
Organization:
Progen Pharmaceuticals
Organization Data
Organization:
Progen Pharmaceuticals
Class:
INDUSTRY
Study ID:
PROGEN-SL002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Progen Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |